Kristen Stants - Aug 2, 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)

Role
Chief People Officer
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Kristen Stants
Stock symbol
DNTH
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
4
Date filed
8/3/2021, 04:34 PM
Next filing
Sep 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Award $0 +67.5K $0.00 67.5K Aug 2, 2021 Common Stock 67.5K $7.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 16 equal quarterly installments beginning on August 2, 2021.